Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.3818
-0.0060 (-1.55%)
At close: Jun 18, 2026, 4:00 PM EDT
0.3822
+0.0004 (0.10%)
After-hours: Jun 18, 2026, 5:16 PM EDT
Scienture Holdings Employees
As of December 31, 2025, Scienture Holdings had 9 total employees, including 4 full-time and 5 part-time employees. The number of employees decreased by 10 or -52.63% compared to the previous year.
Employees
9
Change (1Y)
-10
Growth (1Y)
-52.63%
Revenue / Employee
$53,075
Profits / Employee
-$4,650,059
Market Cap
15.51M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | -10 | -52.63% | 4 | 5 |
| Dec 31, 2024 | 19 | 0 | - | 14 | 5 |
| Jun 30, 2024 | 19 | - | - | 14 | 5 |
| Dec 31, 2023 | 19 | - | - | 14 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 390,000 |
| Johnson & Johnson | 138,200 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| Adagio Medical Holdings | 41 |
| Curis | 24 |
| Lexaria Bioscience | 7 |
| GT Biopharma | 1 |
SCNX News
- 9 hours ago - Scienture announces progress in commercialization of Arbli - TheFly
- 9 hours ago - SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide - GlobeNewsWire
- 9 days ago - SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team - GlobeNewsWire
- 14 days ago - SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC - Accesswire
- 16 days ago - Scienture reveives U.S. patent covering Rezenopy Nasal Spray - TheFly
- 16 days ago - SCIENTURE Receives U.S. Patent Covering REZENOPY™ (Naloxone HCl) Nasal Spray 10 mg, Strengthening Intellectual Property Protection Through 2041 - GlobeNewsWire
- 4 weeks ago - SCIENTURE Reports First Quarter 2026 Financial Results and Business Update Highlighted by Significant Revenue Growth and Gross Margin Expansion - GlobeNewsWire
- 6 weeks ago - Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline - GlobeNewsWire